Chuck Norris sues gadolinium manufacturers, claims wife was poisoned

Melissa Rohman | | Health Imaging | Cardiac Imaging

Acclaimed action star Chuck Norris filed a lawsuit Wednesday, Nov. 1, alleging gadolinium from MRI imaging scans has poisoned his wife, Gena, and is seeking more than $10 million in damages to cover her medical expenses. The suit names several manufacturers of gadolinium contrast agents.

According to a recent article from The Washington Post, the lawsuit states that Norris' wife has been left feeling week and tired with "debilitating bouts of pain and a burning sensation" due to gadolinium usage to improve clarity of her MRI scans. 

“One of the problems is this is a very misdiagnosed and underdiagnosed condition,” said Todd Walburg, an attorney for the Norris family. 

For more information, see the orginal article here.  

Chuck Norris sues over MRI chemical he says poisoned wife

""
Melissa Rohman

A recent graduate from Dominican University (IL) with a bachelor’s in journalism, Melissa joined TriMed’s Chicago team in 2017 covering all aspects of health imaging. She’s a fan of singing and playing guitar, elephants, a good cup of tea, and her golden retriever Cooper.

Related Content

GE HealthCare launches new cardiac CT scanner with advanced AI capabilities
New scanners and strategies for the ‘golden age of CCTA’
Bracco updates HeartSee coronary flow capacity software with new diagnostic features
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor
FDA clears AI-assisted CCTA software that assesses plaques for signs of heart disease
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.